It was known that TSC1 or TSC2 gene mutations in TSC patients may cause the neurodegeneration and the development of benign tumors, such as liver or renal angiomyolipomas, renal cell carcinomas, and hamartomas et al. [11–13]. The gene discussed is TSC1; the disease is renal cell carcinoma.